Introduction
The in vivo CD8 + T cell responses consist of three main phases (1) . These are (i) a proliferation phase that involves the growth and differentiation of naïve CD8 + T cells into effector T cells; (ii) a contraction or transition phase that entails the transition from the large population of effector CD8 + T cells to a smaller population (≈ 5-10%) of long-lived CD8 + memory T (Tm) cells (2) ; and (iii) a maintenance phase that is comprised of long-term CD8 + Tm cell survival in the host. The long-lived CD8 + Tm cell population can be rapidly reactivated and expanded upon Ag restimulation for recall responses. Recently, the phenotypes of these long-lived CD8 + Tm cells have been characterized to be CD44 + , CD62L high and CD127 + (3) . A three-signal model accounts for many aspects of CD8 + T cell activation, namely, stimulation of antigen (Ag) (signal 1), costimulation (signal 2), and a third signal that can be provided by IL-12 (4) derived from mature dendritic cells (DCs) (5) . In absence of signal 3, recognition of antigen leads to the induction of tolerance even when levels of costimulatory ligands are high (6) . Stimulation by Ag in vivo in the absence of IL-12 results in multiple rounds of cell division, but however, the clonal expansion is somewhat limited since the signal 3 is required to promote cell survival. Furthermore, stimulation in the absence of signal 3 results in a failure of the development of cytolytic effector functions. Recently, it has also been shown that IL-12 priming during in vitro Ag stimulation changes properties of CD8 + T cells and increases generation of CD8 + effector and memory T cells (7) . However, the potent functional property of CD8 + Tm cells without IL-12 priming for secondary expansion upon Ag re-encounter is still unclear. In addition, the role of IL-12 signaling in survival of CD8 + effector T cells in the transition phase is also unclear.
In 
Preparation of bone marrow-derived DCs
The preparation of bone marrow-derived DCs was previously described (11) . The OVA-pulsed DCs which were generated from the bone marrow cells of C57BL/6 and C57BL/6 (IL-12 -/-) mice were termed DC OVA and (IL-12 -/-)DC OVA , respectively.
Phenotypic characterization of CD8
+ T cells For phenotypic analysis, DC OVA and (IL-12 -/-)DC OVA were incubated with a panel of biotin-conjugated Abs (2 μg/ml) for 1 h on ice, washed with PBS, and then incubated for 1 h on ice with FITC-conjugated avidin. After another three washes with PBS, the above cells were analyzed by flow cytometry.
CD8
+ T cell proliferation assays To assess the functional effect, we performed in vitro CD8 + T cell proliferation assay. Irradiated (4, + T cells derived from OT I or OT I/B6.1 mice were prepared as described (11) . The purified CD8 + T cells (3 × 10 5 cells/ml) were stimulated with irradiated (4,000 rad) DC OVA or (IL-12 -/-)DC OVA (2 × 10 5 cells/ml) in culture medium with IL-2 (20 U/ml) and with or without recombinant IL-12 (10 ng/ml) for three days as described (12) . + Tm cells were then purified from these PE-tetramer-stained T cells using anti-PE-microbeads (Beckman Coulter).
+ T cell survival Naїve C57BL/6 or C57BL/6(IL-12 -/-) mice were i.v. injected with CD8
+ T and CD8 + T(IL-12 -/-) cells (8 × 10 6 cells per mouse) or purified CD8 + Tm cells (1.5 × 10 6 cells per mouse). An H-2K b /OVA 257-264 tetramer staining assay was performed to examine the amount of OVA-specific CD8 + T cells in the mouse peripheral blood at indicated time points after the adoptive transfer (13) . Three months after adoptive transfer, mice were boosted by i.v. injection of irradiated (4,000 rad) DC OVA (0.5 × 10 6 cells per mouse). Four days after the boost, the tail blood samples from these mice were stained as described above, and analyzed by flow cytometry. + T cell population at day 6 after the T cell transfer. They all expressed CD45.1 ( Figure 2C ), indicating that they are derived from the originally transferred T cells. The numbers of OVA-specific CD8 + T cells detected in peripheral blood then gradually dropped to 7.5% and 5.5% at day 14, and 2.1% and 1.0% at day 30, and then remained stable for at least 3 months after adoptive transfer ( Figure 2B ). There is no significant difference in survival between DC OVA -and (IL-12 -/-)DC OVA -activated T cells (p > 0.05), indicating that DC OVA -activated CD8 + T cells have a similar capacity for survival in vivo, compared to (IL-12 -/-) DC OVA -activated CD8 + T cells. The CD8 + T cells derived from in vitro stimulation of (IL-12 -/-)DC OVA in presence of the recombinant IL-12 also had a similar capacity for in vivo survival after the adoptive transfer (data not shown).
Results and Discussion

Memory CD8 + T cells developed from non-IL-12-primed effector T cells have defective capacity of expansion upon antigen re-encounter
Since the long-term survival CD8 + T cells should be considered to be Tm cells with the capacity of expansion upon antigen stimulation (14), we boosted the mice with OVA-pulsed DC OVA three months after the adoptive transfer. We then measured the number of OVA-specific CD8 + T cells in the peripheral blood 4 days after the boost. Interestingly, the expanded OVA-specific CD8 + Tm cells in mice with transfer of DC OVA -and (IL-12 -/-)DC OVA -activated CD8 + T cells accounted for 28% and 4.2% of the total CD8 + T cell population, respectively ( Figure 2D) further confirm the above finding, we performed an in vivo kinetic study. As shown in Figure 3 , the amount of OVA-specific CD8 + T cells (4.65% versus 2.48% and 0.39% versus 0.28% in the total of CD8 + T cells) was detected in DC OVA and (IL-12 -/-)DC OVA immunized mice 6 and 60 days after DC immunization, respectively. We then measured the number of OVA-specific CD8 + T cells in the peripheral blood 4 days after the boost of DC OVA . Interestingly, the expanded OVA-specific CD8 + Tm cells accounted for 4.53% and 1.17% of the total CD8 + T cell population in mice immunized with DC OVA and (IL-12 -/-) DC OVA , respectively (Figure 3 ), which represents a significant difference (p < 0. priming is important in the generation of CD8 + Tm cells both in quantity and functional quality. The molecular mechanism responsible for the defective capacity of CD8 + Tm cells for secondary expansion, which is derived from lack of IL-12 priming, is unclear. However, there are points related to the potential mechanism which should be considered for future investigation. For example, rapid responses to external stimuli are facilitated by the organization of signaling molecules downstream of the TCR in distinct lipid rafts (15) leading to impairment of further stimulatory responses. Bcl-6 is essential for memory B cell development in germinal center (16) . It has recently been demonstrated that Bcl-6 also plays a role in generation and maintenance of CD8 + Tm cells induced in responses to Ag stimulation (17) . More recently, it has been shown that CD8 + Tm cells developed in the absence of CD4 + Th cells have a defective response for rapid cytokine production upon re-encounter with Ag and exhibit increased DNA methylation at the IL-2 promoter region (18) , indicating that epigenetic modeling provides a molecular basis for the maintenance of a "ready-to-respond" state of CD8 + Tm cells.
IL-12 signaling is not involved in CD8 + Tm cell survival and recall responses
To investigate the role of IL-12 signaling in CD8 + Tm cell survival in vivo, we first generated OVA-specific CD8 + Tm cells by immunization of mice with the recombinant bacteria rLM-OVA. Three months after the immunization, OVAspecific CD8 + T cells in mouse peripheral blood were analyzed by flow cytometry. As shown in Figure 4A , the OVA-specific CD8 + T cells detected in mouse peripheral blood accounted for 24% of the total CD8 + T cell population. They expressed CD44, CD127 and a high amount of CD62L, indicating that they become CD8 + memory T cells (3) . We then transferred the purified CD8 + Tm cells into wild-type C57BL/6 and IL-12 gene KO mice and measured the OVA-specific CD8 + T cells in mouse peripheral blood at different time points after the adoptive transfer. As shown in Figure 4B , the numbers of detected OVA-specific CD8 + T cells in peripheral blood of C57BL/6 mice and mice with IL-12 gene KO were similar at different time points after the adoptive transfer, indicating that the host-derived IL-12 signaling is not involved in the donor CD8 + Tm cell survival in vivo. To investigate the role of IL-12 signaling in CD8 + Tm cell expansion, the mice were boosted with DC OVA or (IL-12 -/-)DC OVA . Four days after the boost, we measured the number of OVA-specific CD8 + T cells in the peripheral blood. As shown in Figure 4C , OVA-specific CD8 + Tm cells expanded 12-14 fold no matter the boost from either DC OVA or (IL-12 -/-)DC OVA , indicating that the host-and donor cellderived IL-12 signaling is not involved in the donor CD8 + Tm cell recall responses upon reencounter of antigen stimulation.
Taken together, we demonstrated that IL-12 priming is important in CD8 + T cell clonal expansion in the proliferation phase and in generation of CD8 + Tm cells with capacity of secondary expansion upon antigen reencounter. However, IL-12 signaling is not involved in CD8 + Tm cell survival and recall responses. Therefore, this study provides potentially useful information for vaccine design and development.
